Cancer is one of the most feared and aggressive diseases in the world and is responsible for more than 9 million deaths universally. Staging cancer early increases the chances of recovery. One staging technique is RNA sequence analysis. Recent advances in the efficiency and accuracy of artificial intelligence techniques and optimization algorithms have facilitated the analysis of human genomics. This paper introduces a novel optimized deep learning approach based on binary particle swarm optimization with decision tree (BPSO-DT) and convolutional neural network (CNN) to classify different types of cancer based on tumor RNA sequence (RNA-Seq) gene expression data. The cancer types that will be investigated in this research are kidney renal clear cell carcinoma (KIRC), breast invasive carcinoma (BRCA), lung squamous cell carcinoma (LUSC), lung adenocarcinoma (LUAD) and uterine corpus endometrial carcinoma (UCEC). The proposed approach consists of three phases. The first phase is preprocessing, which at first optimize the high-dimensional RNA-seq to select only optimal features using BPSO-DT and then, converts the optimized RNA-Seq to 2D images. The second phase is augmentation, which increases the original dataset of 2086 samples to be 5 times larger. The selection of the augmentations techniques was based achieving the least impact on manipulating the features of the images. This phase helps to overcome the overfitting problem and trains the model to achieve better accuracy. The third phase is deep CNN architecture. In this phase, an architecture of two main convolutional layers for featured extraction and two fully connected layers is introduced to classify the 5 different types of cancer according to the availability of images on the dataset. The results and the performance metrics such as recall, precision and F1 score show that the proposed approach achieved an overall testing accuracy of 96.90%. The comparative results are introduced, and the proposed method outperforms those in related works in terms of testing accuracy for 5 classes of cancer. Moreover, the proposed approach is less complex and consume less memory.
I. INTRODUCTION
Cancer Cancer is a general term that used to describe a group of diseases associated with abnormal cell growth with metastatic and invasive characteristics [1] . In 2018, cancer was responsible for more than 9 million deaths worldwide. Approximately 17% of females and 20% of males will have cancer at some point in time, and 10% of females and 13% of The associate editor coordinating the review of this manuscript and approving it for publication was Victor Hugo Albuquerque . males will die from it [2] . Based on statistics from the WHO, every year, more than 8 million people die from cancer, accounting for approximately 13% of deaths worldwide, indicating that cancer is one of the most threatening diseases in the world [1] . In 2018, lung cancer (1.76 million deaths) and colorectal cancer (860,000) are recorded as the most common cancers. Stomach cancer (780,000), liver cancer (780,000), and breast cancer (620,000) ranked second, third and fourth among the most common cancers [2] .
A tumor is any irregular cell proliferation that may be either benign or malignant. A benign tumor remains limited to its original location, which does not invade normal tissue or spread to distant locations of the body. Nevertheless, a malignant tumor may invade normal tissue and spread throughout the body through the circulatory or lymphatic systems (metastasis). The majority of cancers are classified into one of three major groups: carcinomas, sarcomas, and leukemias or lymphomas. Carcinoma is a type of cancer that develops from epithelial cells, accounting for 90% of cancers in human. Histological forms of carcinoma include adenocarcinoma, squamous cell carcinoma, adenosquamous carcinoma, anaplastic carcinoma and large cell carcinoma.Grading of carcinomas refers to the employment of criteria intended to semi-quantify the degree of cellular and tissue maturity seen in the transformed cells relative to the appearance of the normal parent epithelial tissue from which the carcinoma derives. The grades vary from grade 1 to grade 4 [1] .
The Cancer Genome Atlas (TCGA) is a landmark genomics cancer data set including gene expression, DNA methylation, somatic mutation, copy number variation, microRNA expression, and protein expression. These expressions are sequenced and molecularly characterized over 11,000 cases of primary cancer samples. A joint project was established between the National Cancer Institute (NCI) and the National Human Genome Research Institute (NHGRI) under the name of TCGA. In 2006, TCGA was treated as a pilot project. Its focus was on three cancer types: lung, ovarian, and glioblastoma. In 2009, NHGRI and NCI reauthorized TCGA for a complete production phase, due to the significant success of the initial efforts. In the following decade, TCGA collected more than 11,000 cases across 33 tumor types and generated a large, comprehensive database describing the molecular changes that occur in tumours [3] , [4] . Those large datasets provided a great classification opportunity for the global landscape of aberrations at RNA, DNA and protein levels [5] .
This paper proposes an optimized deep learning approach based on BPSO-DT and CNN to classify normal and tumor conditions depending on a high-dimensional RNA-Seq gene expression data. For a high level of accuracy in classification, the high-dimensional RNA-seq data has been optimized with BPSO-DT to reduce its dimensions by selecting only the best features and removing the irrelevant features. Then to input the optimized RNA-seq results into the CNN architecture, the results were embedded into 2-D images. To avoid overfitting, different data augmentation techniques have been applied to the 2D images. The proposed approach was trained and evaluated on a public RNA-seq dataset consists of five separate cancer types, namely kidney renal clear cell carcinoma (KIRC), uterine corpus endometrial carcinoma (UCEC), breast invasive carcinoma (BRCA), lung adenocarcinoma (LUAD) and lung squamous cell carcinoma (LUSC).
The remainder of this paper is organized as follows. Section II presents the methods and materials that discuss the background of this work, while Section III explores related work. Section IV discusses the dataset. Section V illustrates the proposed approach, while Section VI discusses our outcomes and issues in the paper. Finally, Section VII provides conclusions and directions for further research.
II. METHODS AND MATERIALS A. BINARY PARTICLE SWARM OPTIMIZATION
Particle swarm optimization (PSO) is a stochastic optimization technique developed by Kennedy and Eberhart [6] . PSO is a population-based search algorithm based on the organism's behavior on a social milieu, of which a bird flock or a fish school are representative examples [7] . PSO involves simple mathematics and does not require high computational speeds. Moreover, it uses a small number of parameters to adjust and similar parameters can be used for various continuous optimization problems and also the discrete optimization problems such as the feature selection problem [7] . In PSO, every single solution of the target problem is represented by a particle. A group of particles is called a swarm. The whole swarm flies in the D-dimensional search space to find the optimal solutions by updating the position of each particle based on the experience of its own and its neighboring particles. All particles have fitness values, which evaluated using the fitness function, and have velocities that guide the movement of the particles. During movement, the current position of particle i at k iteration is denoted by a vector X k i = (x i1 , x i2 , . . . , x iD ) and the velocity of particle i at k iteration is denoted as V k i = (v i1 , v i2 , . . . , v iD ). Each particle updates its velocity and position depending on two fitness value are the local fitness value (Pbest) and the global fitness value (Gbest) according to equations (1), (2) .
where w is inertia weight, c 1 and c 2 are acceleration constants, r 1 and r 2 are random numbers uniformly distributed between 0 and 1. PSO was originally introduced to solve continues problems. However, there are very discrete problems such as the feature selection problem. Therefore, Kennedy and Eberhart extended PSO to binary PSO (BPSO) [8] to solve discrete problems. In BPSO, equation (1) is still used to update the velocity, where X i , Pbest i and Gbest are limited to take the values 1 or 0, for this reason, the position update equation becomes a probabilistic equation. A sigmoid function sig(V k i ) is used to transform the V k i to the range of (0,1) as shown in equation (3) . According to the update mechanism in BPSO, each particle updates each position based on the particle's velocity, which acts as probability threshold as shown in the probabilistic equation (4) .
where 1 means this feature is chosen as an important feature for the next regeneration and 0 means this feature is not chosen as an important feature to the next regeneration, and rand is a random number ∈ [0, 1].
B. DEEP LEARNING
Traditional image processing techniques provided reasonable results and performance in medical disease detection using infected and uninfected images, but it was limited to small data sets and theoretical results. As deep learning has revolutionized the area of computer vision [9] - [11] , specifically image detection and object classification and recognition, it is now considered as a promising tool to improve such automated diagnosis systems to achieve higher outcomes, widen disease scope, and perform applicable real-time medical imaging [12] - [17] for disease classification systems. Deep learning (DL), as a branch of Artificial Intelligence, depends on algorithms for data processing and thinking process simulation or for developing abstractions [18] - [20] . DL use layers of algorithms to process, analyse and discover hidden patterns in data and human speech understanding, and visually objects recognition [21] - [23] . Information passed through each layer of a deep network, with the output of the previous layer providing input for the next layer. The input layer is the first layer in the network, while output layer is the last layer in the network. All the layers located between the input and output layers are referred to as hidden layers of the network. Each layer is typically a simple, uniform algorithm containing one kind of activation function [18] , [24] .
C. CONVOLUTION NEURAL NETWORKS
Until 2011, CNN analysis was not prominent at computer vision conferences and journals, but in June 2012, a paper by Ciregan et al. [25] at the leading conference CVPR showed how max-pooling CNNs on GPU can dramatically improve many vision benchmark records. In October 2012, a similar system introduced by Krizhevsky et al. [26] won the large-scale ImageNet [27] competition by achieving a significant classification accuracy margin over classical ma-chine learning methods. In November 2012, Ciresan et al.'s [28] system also won the ICPR contest on the analysis of large medical images for cancer detection and in the following year, it won the MICCAI Grand Challenge on the same topic.
In the following years, various advances in deep CNNs further reduced the error rate on the ImageNet task. Several representative CNNs like VGGNet [29] , GoogLeNet [30] , and Residual Neural Network (ResNet) [31] demonstrated significant improvements in successive ImageNet Large-Scale Visual Recognition Competition (ILSVRC) annual challenges. A model called Xception [32] was introduced that uses depth-wise separable convolutions to outperform the Inception-V3 model [33] on the ImageNet [27] dataset classification task. A new CNN variant called densely connected convolutional networks (DenseNet), introduced by Huang et al. [34] , utilizes a network architecture in which each layer is directly connected to every later layer. DenseNet has achieved noticeable improvements over the state-of-theart while using significantly fewer parameters and computations.
III. RELATED WORK
This section conducts a survey on the latest studies for applying deep learning and machine learning in the field of tumor gene expression data. Researchers worldwide have begun to apply machine and deep learning tools to obtain significant results in a wide variety of medical image analyses/understanding tasks. In [35] , Hsu et al. uses RNA sequencing data from The Cancer Genome Atlas (TCGA), and they focus on classifying 33 types of cancer patients. The authors introduced five machine learning algorithms, namely, DT, KNN, linear support vector machine (linear SVM), polynomial support vector machine (poly SVM), and an artificial neural network (ANN). The best result shows that linear SVM is the best classifier in this study, with a 95.8 Lyu and Haque [36] designed a new method to discover potential biomarkers for each tumor type. Based on the pan-cancer atlas, the method was provided with abundant information on 33 prevalent cancer tumor types. They used a convolutional neural network to classify tumor types and used a visualization neural network method to discover top tumor genes from the input. The high-dimensional RNA-Seq data was embedded into 2-D images and was used as a convolutional neural network to make classification of the 33 cancer tumor types. Based on the idea of Guided Grad Cam, as to each class, they generated a significance heat-map for all the genes. The proposed system achieved 95.59% using a train/test split.
The authors [5] undertook the development of a pan-cancer atlas to recognize 9,096 TCGA tumor samples representing 31 tumor types. They randomly assigned 75% (approximately 6800 samples) of samples into the training set and 25% (approximately 2300 samples) into the testing set, proportionally allocating samples from each tumor type. For the non-sex-specific tumor classification, they eliminated all tumor types that are sex-specific, namely, BRCA, CESC, OV, PRAD, TGCT, UCEC, and UCS. For the remaining tumor types, the samples were separated into two groups based on the patient gender. Three additional tumor types (CHOL, DLBC, and KICH) were eliminated due to small gender-specific sample sizes. The authors applied the genetic algorithm and k-nearest neighbours (KNN) methods to iteratively generate the subset of the genes (features) and then use the KNN method to test the accuracy. This method achieved an accuracy of 90% across 31 tumor types and generated a set of top genes for all the tumor types. The deep learning method was also used to classify top tumor genes and identify individual cancer types. In paper [37] , the authors first used a stacked denoising autoencoder (SDAE) to extract high-level features from high-dimensional gene expression profiles. The authors then input these features into a single-layer ANN network to decide whether the sample is a cancerous tumor or not. The accuracy using this method reached 94%. The results and analysis illustrate that these highly interactive cancer genes could be useful for the detection of breast cancer.
Xiao et al. [38] presented a semi-supervised deep learning strategy called the stacked sparse auto-encoder (SSAE) to classify and predict cancer tumor using RNA-seq data. The proposed SSAE-based method employs the pre-training gredey layer approach and a sparsity penalty term to capture and extract important information from the high-dimensional data and then classify the samples. The proposed SSAE model was tested on three public RNA-seq data sets of three types of cancers, lung adenocarcinoma (LUAD), stomach adenocarcinoma (STAD) and breast invasive carcinoma (BRCA). They compared the prediction performance with several commonly used classification methods. The proposed SSAE-based semi-supervised learning model achieves the best classifications of 98.15%, 96.23%, and 99.89% for the STAD, BRCA and LUAD datasets, respectively. Xiao et al. [39] also demonstrated a new strategy, which used deep learning for an ensemble approach that incorporates multiple different machine learning models. The proposed deep learning-based multi-model ensemble method was applied to three public RNA-seq datasets representing three kinds of cancers, lung adenocarcinoma (LUAD), stomach adenocarcinoma (STAD) and breast invasive carcinoma (BRCA). It obtains improved predictions of 99.20%, 98.41%, and 98.78% for the LUAD, BRCA, and STAD datasets, respectively.
IV. TUMOR GENE EXPRESSION DATASET
The tumor gene expression dataset used in this research was published in [40] . It consisted of the RNA sequencing values from tumor samples belonging to five separate cancer types: lung adenocarcinoma (LUAD), lung squamous cell carcinoma (LUSC), breast invasive carcinoma (BRCA), kidney renal clear cell carcinoma (KIRC) and uterine corpus endometrial carcinoma (UCEC). This dataset contains 2,086 rows and 972 columns, each row contains a specific sample, and each column contains the RPKM RNA-Seq values of a specific gene. The last column contains the cancer categories encoded numerically: 1 = BRCA, 2 = KIRC, 3 = LUAD, 4 = LUSC, 5 = UCEC. The number of samples for each tumor category is illustrated in Table 1 .
V. PROPOSED ARCHITECTURE
The proposed architecture consists of three phases. The first phase is the pre-processing, while the second phase is the data augmentation. Deep learning training is the third phase, which relies on the deep N.
Algorithm 1 Extraction the Important Features of RNA-Seq
Input : Tumor gene expression dataset Output: Gbest position 1 Initialize the position and velocity of each particle randomly 2 while iteration condition is not satisfied do 3 Evaluate the fitness of the particle swarm by DT according to equation 5 4 for each particle i do 5 if the fitness of x i is greater than the fitness of the Pbest i then 6 Pbest i = x i 7 end 8 if the fitness of any particle of the swarm is greater than Gbest then 9 Gbest = particle's position In this phase, BPSO is applied to implement the feature selection, and the decision tree (DT) [8] is used as BPSO's fitness function for a classification problem. In the context of this work, BPSO is used to reduce the number of RNA-seq features to a minimum and select only important features, and increase the accuracy of the classification. Therefore, the fitness function is calculated as equation (5) [41] .
where α is a hyperparameter that decides the tradeoff between the classifier performance C p , and the size of the feature subset S f with respect to the total number of features T f . In this work the classifier performance is the accuracy. The steps of BPSO-DT are presented in Algorithm 1, where the input is the tumor gene expression dataset consisting of RNA-seq that needs optimization. By following all steps 1 through 16 mentioned in Algorithm 1, the Gbest position representing the best specific features of RAN-seq is returned. During this experiment, the parameters of BPSO were set as follows: the maximum number of iterations = 10, number of particles = 600, c 1 = c 2 = 1.5, w = 0.7, v max = 6, v min = −6, and D = 971 which is the dimension of the dataset used.
In BPSO-DT processing, 615 features out of 971 features were chosen as the best features of RNA-seq. Then, a set of steps have been applied to the optimized tumor gene expression dataset to convert it from data format to image format. The preprocessing phase include 1) loading the tumor gene expression on memory, 2) Change the data numerical domain range from [0, 24248] to image range [0, 255] according to equation (6), 3) Construct image by converting the optimized data record of 615 cells into a 25 × 25 pixels image. The result of this phase will be 2086 images classified into 5 tumor categories. Figure 1 illustrates a set of images after the preprocessing phase.
PixelValue = Round
Cell Value * 255 24248 (6) where 24248 is the maximum cell value in the tumor gene expression data, and 255 is the maximum value of the image domain. 
B. DATA AUGMENTATION PHASE
The proposed architecture for the deep learning model, which will be presented in the section on the following phase, has a huge number of learnable parameters compared to the number of images in the training set. The original dataset after the preprocessing phase contains 2086 images for 5 classes of tumor gene expression. Because of the great difference between learnable parameters and the number of images in the training set, the model is very likely to overfit. Deep learning models perform better with large datasets. One very widespread way to make datasets bigger is data augmentation or jittering. Data augmentation can increase the size of the dataset up to 10 or 20 times the original one or more, which helps avoid overfitting when training on very little data. The approach assists in building simpler and robust models which can generalize better. In this section, the common techniques that have been used in this research for overcoming the overfitting problem are presented.
C. AUGMENTATION TECHNIQUES
The most common method to overcome overfitting is to increase the number of images used for training by applying label-preserving transformations. In addition, data augmentation schemes are applied to the training set to make the resulting model more invariant to reflection, zooming and small noise in pixel values. To apply augmentation, each image in the training data is transformed as follows:
• Reflection around X axis, • Reflection around Y axis, • Reflection around X-Y axis, • Zooming. The mentioned data augmentation techniques have been applied to the dataset, this raises the dataset a number of images from 2086 images to 10430 images, doubled 5 times. This will lead to a significant improvement in the neural network training phase. Additionally, will make the proposed deep learning architecture immune to memorize the data and be more robust and accountable for the testing phase.
D. DEEP LEARNING TRAINING PHASE
This research conducted many experimental trails to propose the following deep learning architecture. Those experiments were already implemented in previous studies in [42] - [46] but the testing accuracy was unacceptable. Therefore, there was a need to propose a new one.
The proposed deep learning architecture of tumor gene expression is introduced in detail in Figure 2 and Figure 3 . A graphical representation of the proposed architecture is shown in Figure 2 . Figure 3 illustrates the layer details of the proposed architecture. The architecture consists of 14 layers, including two convolutional layers for features extraction with different convolution window 3*3 pixels, followed by two fully connected layers for classification.
The first layer is the input layer with input size 25*25 pixels. The second layer is the convolution layer with window size 3*3 pixels and 16 different filters. The third layer is a ReLU, which is used as the nonlinear activation function, then followed by an intermediate pooling with subsampling in layer four. A convolution layer with window size 3*3 pixels and 32 different filters and ReLU activation function are applied in the sixth and seventh layers. A dropout layer is in layer number eight to overcome the overfitting problem. Then, layer nine is a fully connected layer with 64 neurons, with a ReLU activation function. The last fully connected layer has 5 neurons to classify 5 classes for the tumor gene expression in layer number thirteen and uses a softmax layer to obtain the class memberships.
VI. EXPERIMENTAL RESULTS
The proposed architecture was developed using a software package (MATLAB). The implementation was GPU specific. All experiments were performed on a computer server with an Intel Xeon E5-2620 processor (2 GHz), 32 GB of RAM and 12 GB Nvidia GTX Titan X. 
A. TESTING ACCURACY MEASUREMENT
To measure the accuracy of the proposed architecture for tumor gene expression using deep convolutional neural networks, 5 different trials were performed, and the median accuracy was calculated for different training and testing splitting. This research adopted three splitting strategies to evaluate the proposed architecture. The first strategy is splitting the data into 60% for training and 40% for testing, while the second strategy is splitting the data into 70% for training and 30% for testing. The last strategy is splitting the data into 80% for training and 20% for testing. The confusion matrices for the different strategies are presented in Figure 4 , 5, and 6. Figure 4 , 5, and 6 illustrates that the more data is used for training phase the more accuracy the model will achieve. Table 2 summarizes the achieved median accuracy for the different adopted training and testing strategies with/without BPSO-DT. The proposed deep learning architecture for tumor gene expression had achieved median testing accuracy with 96.90% in the 80% training and 20% testing strategy with BPSO-DT, which means that the using BPSO-DT algorithm and more data the architecture had, the better accuracy the architecture could achieve.
Another measure of performance is the progress of validation accuracy through the training phase. The progress of VOLUME 8, 2020 validation accuracy shows the improvement of the leaning process. Figure 7 presents the progress of the validation accuracy through the training process while Figure 8 illustrates samples of testing classification accuracy using the proposed architecture.
B. PERFORMANCE EVALUATION AND DISCUSSION
To evaluate the performance of the proposed architecture, more performance measures need to be investigated through this research. The most common performance measures in the field of deep learning are Precision, Recall, and F1 Score [47] and are presented in equation (7), equation (8) and equation (9) .
where The TP is an acronym for ''True Positive'' which represents the outcome where the model correctly predicts the positive class. Accordingly, The TN is an acronym for ''True Negative'' which represents the outcome where the model correctly predicts the negative class. Moreover, The FP is an abbreviation for ''False Positive'' which presents the outcome where the model incorrectly predicts the positive class.
In addition, FN is the abbreviation for ''False Negative'' which presents the outcome where the model incorrectly predicts the negative class. Table 3 represents the values of Precision, Recall and F1 Score for the different adopted training and testing strategies. From the values presented in Table 3 , the 80% training and 20% testing strategies give the best values which reflect the amount of data to be trained, the validation accuracy have been used through the training phase after every epoch as presented in Figure 7 . The black circles showed up in Figure 7 presented the validation accuracy after every epoch of training. Using the augmentation techniques helped in generating more data which lead to a significant improvement in Precision, Recall, and F1 Score values.
Another measure of performance is the progress of validation accuracy through the training phase. The progress of validation accuracy shows the improvement of the leaning process. Figure 7 presents the progress of the validation accuracy through the training process while Figure 8 illustrates samples of testing classification accuracy using the proposed architecture.
The progress of validation accuracy has been improved through the training phase as after every epoch, the validation accuracy has been calculated and presented in Figure 7 with black circles while blue lines are the training accuracy.
The work presented in this research is novel in terms of pre-processing phase which include optimization process and the design of deep learning architecture. One of the related works presented in [36] made a similar contribution to ours. Table 4 illustrates the main difference between work presented in [36] and our presented work. The question that may raise itself in this section why compare our work with work presented in [36] and why not compared with the other related work in [5] , [35] , [38] , [39] .The main reason is the work presented in [36] uses the same methodology similar to ours which included converting the RNA sequence to images then applying deep learning models, while the other related works used different methodologies which will be unfair to compare our work with them. Also, the selected dataset [40] which is used in this research in newly published in May 2018, it is an open opportunity to experiment the proposed model on this newly published data. Table 4 shows clearly that the proposed architecture in this work had lower training data but using the adopted augmentation techniques gave a better overall testing accuracy with 96.16% beating the related work in terms of overall testing accuracy for 5 classes. Moreover, this work did not apply any type thresholding the values and consider the training of the whole dataset, while the related work had dropped some of thresholding techniques on data. Additionally, the proposed deep learning architecture is power in complexity, as it had only 14 layers. whereas the related work had 23 layers will a huge number of neurons in fully connected layers with 36864 neurons in FC layer number 1 and 1024 FC layer number 2 which will reflect on the time of training on hardware. On the other hand, the related work achieved better testing accuracies for BRCA and LUAD, while ours achieved better testing accuracies for KIRC, LUSC and UCEC. Moreover, the related work was able to identify 33 classes, while this work identifies 5 classes. 
VII. CONCLUSION AND FUTURE WORKS
Cancer is a group of diseases exhibiting abnormal cell growth, which may have the ability to invade or spread to various parts of the human body. This type of disease is responsible for more than 9 million deaths globally. The existence of RNA-Seq currently has greatly boosted the analysis of human genomics due improvements in the efficiency and accuracy, which help in understanding the nature of the cancer diseases. This paper introduced a novel approach to classifying different type of cancer: breast invasive carcinoma (BRCA), kidney renal clear well carcinoma (KIRC), E:at Adenocarcinoma (LUAD), Lung Squamous Cell Carcinoma (LUSC) and Uterine Corpus Endometrial Carcinoma (UCEC). The proposed approach consisted of three phases. The first phase is the pre-processing, which included the optimization process using binary particle swarm optimization with design trees (BPSO-DT) algorithm to select the best features of RNA-Seq then converted it to 2D images. The second phase is the data augmentation, which increased the original dataset volume to types. The presented results and the performance metrics preformed in this research showed that the proposed approach achieved an overall testing accuracy of 96.90%. The comparative results were introduced, and the accuracy achieved in the present work outperforms those of other related work for the testing accuracy for 5 classes of the tumour. Moreover, the proposed approach is less complexity and had less time in training. One of the potential future works is applying new architectures of deep neural networks such as Generative Adversarial Neural networks. GAN will be used before the proposed architecture. It will help in generating new images from the trained images, which will reflect on the accuracy of the proposed architecture. Additionally, to expand the current work to classify the 33 types of cancer if the datasets would be available with different deep learning architecture such as AlexNet, Vgg-16, and google-net.
